Загрузка...
Anti-RNPC3 Antibodies as a Marker of Cancer-Associated Scleroderma
INTRODUCTION: Prior studies have demonstrated an increased risk of cancer-associated scleroderma in patients with RNA polymerase III (POL) autoantibodies and in patients negative for anti-centromere (CENP), anti-topoisomerase-1 (TOPO), and anti-POL antibodies (referred to as CENP/TOPO/POL (CTP)-Nega...
Сохранить в:
| Опубликовано в: : | Arthritis Rheumatol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5449218/ https://ncbi.nlm.nih.gov/pubmed/28217959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40065 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|